Cervicovaginal shedding of HIV type 1 is related to genital tract inflammation independent of changes in vaginal microbiota

AIDS Research and Human Retroviruses

Volumn 27, Issue 1, 2011, Pages 35-39

  Mitchell, Caroline ^a   Hitti, Jane ^a   Paul, Kathleen ^a   Agnew, Kathy ^a   Cohn, Susan E ^b,c   Luque, Amneris E ^c   Coombs, Robert ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; HYDROGEN PEROXIDE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; VIRUS RNA;

ADULT; ARTICLE; BACTERIAL COLONIZATION; CHLAMYDIA TRACHOMATIS; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GENITAL TRACT INFLAMMATION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LACTOBACILLUS; MAJOR CLINICAL STUDY; NEISSERIA GONORRHOEAE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; UNITED STATES; UTERINE CERVIX CYTOLOGY; VAGINA FLORA; VAGINITIS; VIRUS LOAD; VIRUS SHEDDING; YEAST;

ADULT; BACTERIA; CERVIX UTERI; CYTOKINES; FEMALE; FUNGI; HIV INFECTIONS; HIV-1; HUMANS; INFLAMMATION; MIDDLE AGED; RNA, VIRAL; UNITED STATES; VAGINA; VAGINAL DOUCHING; VIRUS SHEDDING;

EID: 78651426734     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2010.0129     Document Type: Article

References (32)

1. Chakraborty H, Sen PK, Helms RW, et al.: Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: A probabilistic empiric model. AIDS 2001; 15(5):621-627.
2. Wilson DP, Law MG, Grulich AE, Cooper DA, and Kaldor JM: Relation between HIV viral load and infectiousness: A model-based analysis. Lancet 2008;372(9635):314-320.
3. Kovacs A, Wasserman SS, Burns D, et al.: Determinants of HIV-1 shedding in the genital tract of women. Lancet 2001; 358(9293):1593-1601.
4. Mostad SB: Prevalence and correlates of HIV type 1 shedding in the female genital tract. AIDS Res Hum Retroviruses 1998;14(Suppl 1):S11-15.
5. Coombs RW, Reichelderfer PS, and Landay AL: Recent observations on HIV type-1 infection in the genital tract of men and women. AIDS 2003;17(4):455-480.
6. Coleman JS, Hitti J, Bukusi EA, et al.: Infectious correlates of HIV-1 shedding in the female upper and lower genital tracts. AIDS 2007;21(6):755-759.
7. Johnson LF and Lewis DA: The effect of genital tract infections on HIV-1 shedding in the genital tract: A systematic review and meta-analysis. Sex Transm Dis 2008;35(11):946-959.
8. Kedzierska K, Crowe SM, Turville S, and Cunningham AL: The influence of cytokines, chemokines and their receptors on HIV-1 replication in monocytes and macrophages. Rev Med Virol 2003;13(1):39-56.
9. Cohn MA, Frankel SS, Rugpao S, et al.: Chronic inflammation with increased human immunodeficiency virus (HIV) RNA expression in the vaginal epithelium of HIV-infected Thai women. J Infect Dis 2001;184(4):410-417.
10. Mitchell CM, Balkus J, Agnew KJ, et al.: Bacterial vaginosis, not HIV, is primarily responsible for increased vaginal concentrations of proinflammatory cytokines. AIDS Res Hum Retroviruses 2008;24(5):667-671.
11. Anton G, Rid J, Mylonas I, Friese K, and Weissenbacher ER: Evidence of a TH1-shift of local vaginal inflammatory response during bacterial vaginosis. Infection 2008;36(2): 147-152.
12. Spear GT, Zariffard MR, Cohen MH, and Sha BE: Vaginal IL-8 levels are positively associated with Candida albicans and inversely with lactobacilli in HIV-infected women. J Reprod Immunol 2008;78(1):76-79.
13. Hedges SR, Barrientes F, Desmond RA, and Schwebke JR: Local and systemic cytokine levels in relation to changes in vaginal flora. J Infect Dis 2006;193(4):556-562.
14. McGowan I, Elliott J, Fuerst M, et al.: Increased HIV-1 mucosal replication is associated with generalized mucosal cytokine activation. J Acquir Immune Defic Syndr 2004;37(2): 1228-1236.
15. Cummins JE, Christensen L, Lennox JL, et al.: Mucosal innate immune factors in the female genital tract are associated with vaginal HIV-1 shedding independent of plasma viral load. AIDS Res Hum Retroviruses 2006;22(8):788-795.
16. Spear GT, Zariffard MR, Chen HY, et al.: Positive association between HIV RNA and IL-6 in the genital tract of Rwandan women. AIDS Res Hum Retroviruses 2008;24(7): 973-976.
17. Clark RA, Theall KP, Amedee AM, and Kissinger PJ: Frequent douching and clinical outcomes among HIV-infected women. Sex Transm Dis 2007;34(12):985-990.
18. Wright TC, Jr., Subbarao S, Ellerbrock TV, et al.: Human immunodeficiency virus 1 expression in the female genital tract in association with cervical inflammation and ulceration. Am J Obstet Gynecol 2001;184(3):279-285.
19. Zuckerman RA, Lucchetti A, Whittington WL, et al.: Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: A randomized, double-blind, placebocontrolled crossover trial. J Infect Dis 2007;196(10):1500-1508.
20. Mostad SB, Kreiss JK, Ryncarz AJ, et al.: Cervical shedding of cytomegalovirus in human immunodeficiency virus type 1-infected women. J Med Virol 1999;59(4):469-473.
21. Corey L, Huang ML, Selke S, and Wald A: Differentiation of herpes simplex virus types 1 and 2 in clinical samples by a real-time taqman PCR assay. J Med Virol 2005;76(3):350-355.
22. Mohamed AS, Becquart P, Hocini H, Metais P, Kazatchkine M, and Belec L: Dilution assessment of cervicovaginal secretions collected by vaginal washing to evaluate mucosal shedding of free human immunodeficiency virus. Clin Diagn Lab Immunol 1997;4(5):624-626.
23. Eschenbach DA, Davick PR, Williams BL, et al.: Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis. J Clin Microbiol 1989;27(2):251-256.
24. Nugent RP, Krohn MA, and Hillier SL: Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991;29(2):297-301.
25. Neely MN, Benning L, Xu J, et al.: Cervical shedding of HIV- 1 RNA among women with low levels of viremia while receiving highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2007;44(1):38-42.
26. Anderson BL, Wang CC, Delong AK, et al.: Genital tract leukocytes and shedding of genital HIV type 1 RNA. Clin Infect Dis 2008;47(9):1216-1221.
27. Ouedraogo A, Nagot N, Vergne L, et al.: Impact of suppressive herpes therapy on genital HIV-1 RNA among women taking antiretroviral therapy: A randomized controlled trial. AIDS 2006;20(18):2305-2313.
28. Cu-Uvin S, Hogan JW, Caliendo AM, Harwell J, Mayer KH, and Carpenter CC: Association between bacterial vaginosis and expression of human immunodeficiency virus type 1 RNA in the female genital tract. Clin Infect Dis 2001;33(6): 894-896. (Pubitemid 32831848)
29. Sha BE, Zariffard MR, Wang QJ, et al.: Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis. J Infect Dis 2005;191(1):25-32.
30. Wang CC, McClelland RS, Reilly M, et al.: The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1. J Infect Dis 2001;183(7):1017-1022.
31. Lawn SD, Subbarao S, Wright TC, Jr., et al.: Correlation between human immunodeficiency virus type 1 RNA levels in the female genital tract and immune activation associated with ulceration of the cervix. J Infect Dis 2000;181(6):1950-1956.
32. 4 T lymphocytes and macrophages into the cervical epithelium of women after coitus. Am J Obstet Gynecol 2003;188(2):376-381.